Anzeige
Mehr »
Donnerstag, 21.05.2026 - Börsentäglich über 12.000 News
Nach dem Tungsten-Schock: Startet hier jetzt die nächste große US-Critical-Minerals-Story?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DRQV | ISIN: SE0009778848 | Ticker-Symbol: 5M0B
Tradegate
21.05.26 | 14:35
19,620 Euro
-0,71 % -0,140
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDICOVER AB Chart 1 Jahr
5-Tage-Chart
MEDICOVER AB 5-Tage-Chart
RealtimeGeldBriefZeit
19,50019,66017:51
19,48019,66017:48

Aktuelle News zur MEDICOVER Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.05.Medicover AB: Medicover signs a EUR 450 million revolving credit facility684Medicover has signed a new EUR 450 million syndicated revolving credit facility agreement. The facility has a maturity of three years with two one-year extension options subject to lenders' approval....
► Artikel lesen
MEDICOVER Aktie jetzt für 0€ handeln
30.04.Dividendenbekanntmachungen (30.04.2026)14.757 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  4IMPRINT GROUP PLC  GB0006640972  1,194 GBP  1,3782 EUR  AB DYNAMICS PLC  GB00B9GQVG73  0,0308 GBP  0,0355 EUR  AGNC INVESTMENT CORP  US00123Q1040  0...
► Artikel lesen
29.04.Medicover AB: Bulletin from annual general meeting in Medicover AB (publ)396The below resolutions were passed at Medicover's annual general meeting (the "AGM") held today on 29 April 2026. Election of the board of directors and auditorThe AGM resolved, in accordance with the...
► Artikel lesen
29.04.Starke Margen in Polen und Indien: Medicover übertrifft Gewinnerwartungen für Q13
29.04.Medicover AB: Interim report January-March 2026443Revenue amounted to EUR 624.2 million (EUR 578.1 million), an increase of 8.0% with an organic growth of 10.3%.Operating pro?t (EBIT) was EUR 46.7 million (EUR 36.0 million), an increase of 30.0% representing...
► Artikel lesen
10.02.Medicover AB Ser. B Q4 Income Rises4
10.02.Medicover AB: Year-end report January-December 2025679Fourth quarterRevenue amounted to €611.7m (€555.8m), an increase of 10.0% with an organic growth of 10.6%.Operating profit (EBIT) was €35.2m (€23.3m), an increase of 50.3% representing an operating...
► Artikel lesen
09.02.Medicover AB: Medicover announces new financial targets - continued organic growth and margin expansion268The board of directors of Medicover AB (publ) ("Medicover") has decided on new financial targets for the three-year period 2026-2028. The new financial targets[1] builds on the successful delivery during...
► Artikel lesen
05.11.25Medicover AB: Interim report July-September 2025413Third quarterRevenue amounted to €591.6m (€527.8m), an increase of 12.1% with an organic growth of 12.4%.Operating profit (EBIT) was €42.8m (€6.7m), representing an operating margin of 7.2% (1.3%).Net...
► Artikel lesen
22.10.25Medicover AB: Additional interim results strengthen the clinical evidence of Medicover Genetics' MRD assay in non-small cell lung cancer327Medicover is proud to announce additional results from the ongoing DART clinical study from Oslo University Hospital. The study utilises Medicover Genetics' hybrid capture-based, tumour-agnostic MRD...
► Artikel lesen
24.07.25Medicover AB: Interim report April-June 2025330Second quarterRevenue amounted to €596.7m (€509.4m), an increase of 17.1% with an organic growth of 13.9%.Operating profit (EBIT) was €41.7m (€21.3m), an increase of 96.5% representing an operating...
► Artikel lesen
18.06.25Medicover AB: Lukasz Krause new Chief Digital Information Officer (CDIO) Medicover515Lukasz Krause will assume the role of CDIO as of 1 July 2025 and be part of the executive management team of Medicover. Lukasz brings a wealth of experience in IT management having successfully overseen...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1